Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2013; 67(1): 45-48.

18FDG-PET/CT diagnostics of pancreatic adenocarcinoma

Pavel Fencl Orcid.org  1

+ Affiliation

Summary

Nowadays, high-resolution scanners are used for 18FDG-PET/CT examination, reaching adiagnostic accuracy of 90% to 95%, to diagnose pancreatic cancer. The advantage of the method is the whole-body examination range, which enables reliable detection of remote bodies of disease generalisation thanks to the high sensitivity of metabolic information. Therefore, 18FDG-PET/CT examination should be included in the pre-surgery consideration as it can lead to higher relative savings of funds despite its higher price, as well as improve post-surgery outcomesby excluding from radical treatment those patients whose disease is generalised at the time of the diagnose.

Keywords

pancreatic carcinoma

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Print

Credited self-teaching test

Start test

Most Read (last 6 month)

  1. Colorectal cancer screening in the Czech Republic
  2. Pancreatic cancer surveillance in high-risk individuals Position statement of professional societies
  3. Trends in premature mortality from digestive system cancers in Slovakia in the years 2011–2020: 8 diagnoses over 10 years
  4. Results from the evaluation of colorectal cancer screening in the Czech Republic
  5. Mixed adenoneuroendocrine carcinoma of the stomach – a case report
  6. Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity
  7. Urolithiasis in patients with inflammatory bowel disease – possibilities of prevention and metabolic influence
  8. Subcutaneous infliximab – treatments and new possibilities after clinical practice